Cirata (GB:CRTA)
LSE:CRTA
Want to see GB:CRTA full AI Analyst Report?
Top Page
Cirata
(LSE:CRTA)
Select Model
Select Model
Rating:53Neutral
Price Target:
17.00 p
▼(-19.05% Downside)
Action:ReiteratedDate:04/30/26
The score is driven mainly by mixed financial performance: strong revenue acceleration and very high gross margins, but still significant losses and ongoing negative free cash flow. Technicals are moderately positive in the short term (above 20/50 DMA with positive MACD), while longer-term trend remains weak (below 100/200 DMA). Valuation is supported by a very low P/E, with no dividend data available.
Positive Factors
High gross margins
Cirata's ~90%+ gross margins reflect a software subscription/support model with low incremental costs, enabling significant operating leverage as revenue scales. Durable high margins create a clear pathway to profitability if sales and G&A growth are controlled, supporting long-term margin sustainability.
Negative Factors
Sustained net losses
A ~-60% net margin in 2025, despite improvement from prior years, indicates the business is far from self-sustaining. Continued heavy losses erode equity and limit reinvestment capacity; unless operating losses convert to sustained positive margins, the firm will face ongoing financing pressure over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
High gross margins
Cirata's ~90%+ gross margins reflect a software subscription/support model with low incremental costs, enabling significant operating leverage as revenue scales. Durable high margins create a clear pathway to profitability if sales and G&A growth are controlled, supporting long-term margin sustainability.
Read all positive factors
Cirata (CRTA) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£20.97M
Dividend YieldN/A
Average Volume (3M)311.29K
Price to Earnings (P/E)1.3
Beta (1Y)0.29
Revenue Growth48.92%
EPS Growth45.58%
CountryUK
Employees103
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)0.04
Shares Outstanding126,340,250
10 Day Avg. Volume624,016
30 Day Avg. Volume311,286
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)2.99
Price to Sales (P/S)2.52
P/FCF Ratio-3.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£44.00Price Target Upside109.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.02
Revenue Forecast (FY)£11.70M
Cirata Business Overview & Revenue Model
Company Description
Cirata plc, together with its subsidiaries, engages in the development and provision of collaboration software in North America, Europe, China, and internationally. The company's WANdisco Data Activation Platform offers Data Migrator, an automated...
How the Company Makes Money
Cirata primarily makes money by selling commercial subscriptions and support for its enterprise data platform (commonly packaged as an enterprise Hadoop distribution/management stack). Revenue is typically generated through (1) recurring subscript...
Cirata Earnings Call Summary
Earnings Call Date:Sep 03, 2025
(Q2-2025)
| % Change Since: |
Next Earnings Date:Sep 09, 2026
Earnings Call Sentiment Neutral
Cirata's earnings call indicates strong revenue and bookings growth, effective cost management, and strategic partnerships, paired with challenges in sales execution and customer acquisition. While there are significant achievements, the need for improved execution in certain areas tempers overall enthusiasm.Positive Updates
Significant Revenue Growth
Revenue for the first half of 2025 rose to $4.8 million, up from $3.4 million a year ago, marking an increase of over 40%.
Negative Updates
Disappointing Q2 Performance
Q2 results were below expectations, failing to demonstrate consistent quarterly progress.
Read all updates
Q2-2025 Updates
Positive
Negative
Significant Revenue Growth
Revenue for the first half of 2025 rose to $4.8 million, up from $3.4 million a year ago, marking an increase of over 40%.
Read all positive updates
Company Guidance
In the recent call, Cirata reported significant progress in the first half of fiscal year 2025, with revenues rising over 40% to $4.8 million from $3.4 million a year ago, and bookings increasing by 58% to $3.8 million. The company achieved a notable reduction in cash overheads, from $11.8 million to $8.5 million, contributing to the halving of its adjusted EBITDA loss from $8.6 million to $4 million. Cirata ended June with a cash plus receivables position of $7.4 million. The data integration segment, a core focus for Cirata, showed robust growth, with bookings in this area soaring over 200% year-on-year to $3.1 million. Despite a disappointing Q2, the first half data integration bookings were up significantly, and the company successfully signed 20 contracts, including an enterprise-wide license with a top retailer. Strategic moves, such as divesting DevOps assets to BlueOptima, resulted in up to $3.5 million in cash and allowed Cirata to concentrate on its data integration business. Additionally, the appointment of Dominic Arcari as Chief Revenue Officer is expected to enhance sales execution. The outlook remains positive, with expectations of continued triple-digit growth in data integration and no further working capital fundraise needed in FY '25.Cirata Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
62
Positive
Cash Flow
34
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.12M | 7.68M | 6.70M | 9.69M | 7.31M |
| Gross Profit | 11.18M | 7.14M | 6.06M | 8.99M | 6.65M |
| EBITDA | -4.75M | -14.39M | -36.69M | -39.13M | -32.47M |
| Net Income | -7.26M | -13.51M | -36.48M | -29.61M | -37.59M |
Balance Sheet | |||||
| Total Assets | 13.34M | 14.92M | 23.11M | 26.54M | 42.19M |
| Cash, Cash Equivalents and Short-Term Investments | 3.98M | 9.73M | 18.25M | 19.11M | 27.76M |
| Total Debt | 467.17K | 889.00K | 795.00K | 539.00K | 1.82M |
| Total Liabilities | 3.10M | 5.35M | 6.50M | 8.64M | 7.76M |
| Stockholders Equity | 10.24M | 9.57M | 16.61M | 16.56M | 34.42M |
Cash Flow | |||||
| Free Cash Flow | -8.35M | -14.88M | -30.67M | -27.70M | -34.00M |
| Operating Cash Flow | -8.26M | -14.77M | -30.60M | -27.50M | -28.23M |
| Investing Cash Flow | 2.93M | -107.00K | -43.00K | -158.00K | -5.76M |
| Financing Cash Flow | -575.83K | 6.44M | 29.10M | 19.48M | 40.79M |
Cirata Technical Analysis
Neutral
21.00
Price Trends
16.35
Positive
18.20
Negative
19.21
Negative
Market Momentum
-0.10
Negative
62.15
Neutral
88.52
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CRTA, the sentiment is Neutral. The current price of 21 is above the 20-day moving average (MA) of 14.71, above the 50-day MA of 16.35, and above the 200-day MA of 19.21, indicating a neutral trend. The MACD of -0.10 indicates Negative momentum. The RSI at 62.15 is Neutral, neither overbought nor oversold. The STOCH value of 88.52 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:CRTA.
Cirata Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | £101.39M | 20.36 | 11.98% | 0.79% | 12.10% | 27.35% | |
68 Neutral | £208.13M | 37.63 | 5.22% | 0.80% | 19.00% | -53.85% | |
68 Neutral | £138.25M | -33.80 | -2.11% | ― | 31.86% | -115.22% | |
67 Neutral | £143.74M | 11.95 | 8.80% | 1.68% | 3.82% | -18.43% | |
66 Neutral | £88.11M | 4.25 | 5.57% | ― | -1.34% | 27.45% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
53 Neutral | £20.97M | 1.28 | -268.88% | ― | 48.92% | 45.58% |
* Technology Sector Average
GB:CRTA
Cirata
16.60
-1.65
-9.04%
GB:ACSO
accesso Technology
272.00
-205.00
-42.98%
GB:DOTD
Dotdigital
47.40
-33.70
-41.55%
GB:ELCO
Eleco
120.50
0.28
0.24%
GB:NET
Netcall
122.00
10.95
9.86%
GB:AOM
ActiveOps plc
193.50
84.50
77.52%
Cirata Corporate Events
Business Operations and StrategyShareholder Meetings
Cirata adds RSU incentive plan vote to May AGM agenda
Positive
Apr 23, 2026
Cirata has amended its upcoming annual general meeting agenda to add a resolution seeking shareholder approval for a new Restricted Share Unit plan aimed at attracting, retaining and incentivising key employees and management. The move is designed...
Business Operations and StrategyExecutive/Board Changes
Cirata boosts executive equity incentives with new option grants
Positive
Apr 21, 2026
Cirata has granted share options to three senior executives under its amended and restated Share Options Plan, aligning long-term incentives with shareholder interests as part of the company-wide FY25 bonus framework. Chief executive Stephen Kelly...
Business Operations and StrategyFinancial Disclosures
Cirata posts first cash-flow-positive quarter as pipeline and KPIs boost visibility
Positive
Apr 14, 2026
Cirata plc, a provider of data integration and orchestration software for large enterprises, focuses on automating petabyte-scale data migration, replication and modernization to cloud analytics and AI platforms. The company serves global blue-chi...
Business Operations and StrategyFinancial DisclosuresM&A TransactionsProduct-Related Announcements
Cirata Posts Record Data Integration Bookings as Cost Cuts Sharpen Focus on Growth
Positive
Mar 31, 2026
Cirata reported a pivotal 2025 financial year in which it sharpened its focus on data integration, completed the divestment of its DevOps unit and launched its new Cirata Symphony data orchestration platform. The company secured its largest-ever O...
Executive/Board Changes
Cirata Grants Performance-Linked Share Options to CTO and CRO
Positive
Feb 4, 2026
Cirata plc has granted new equity-based awards under its Share Options Plan to Chief Technical Officer Paul Scott Murphy and Chief Revenue Officer Dominic Arcari, reflecting the board’s use of long-term incentives to align senior leadership ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.